© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
August 25, 2022
More of these treatments have been approved, but supply chain issues and cost remain obstacles.
July 14, 2022
Although the Oncology Care Model produced some positive results, the value-based care model cost Medicare money. Now attention is turning to its successor, the Enhancing Oncology Model.
July 08, 2022
Bispecific antibody therapies are also in development.
June 06, 2022
If biosimilar acceptance is to grow, it’s going to take a great deal of work to improve the levels of trust between payers, patients, and oncologists.
May 12, 2022
Research and discussion about the high cancer rates among Black Americans used to be dominated by genetics and the search for biological differences. Now attention has shifted to the social determinants of health.
April 20, 2022
Patients with cancer who have a poor prognosis may face obstacles in accessing critical pain medications.
March 16, 2022
The American Cancer Society’s 2022 statistical report shows that the 30-year trend is continuing.
February 21, 2022
Dr Al-Hendy discusses the impact UF has on a patient’s life and their typical patient journey through the healthcare system.
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP, provides a comprehensive background on uterine fibroids, explaining everything from clinical burden to symptoms.
February 03, 2022
Biden is reviving the program he headed as vice president with the goal of reducing the cancer mortality rate and improving the experience of patients and their loved ones.